Control-IQ+ technology
Tandem Diabetes Care, Inc. · Clinical Chemistry
Open FDA's page for this record- Third party flag
- N
- City
- San Diego
- Advisory committee description
- Clinical Chemistry
- Address 1
- 12400 High Bluff Dr.
- Statement or summary
- Summary
- Product code
- QJI
- Zip code
- 92130
- Applicant
- Tandem Diabetes Care, Inc.
- Decision date
- 2025-02-24
- Decision code
- SESE
- Country code
- US
- Device name
- Control-IQ+ technology
- Advisory committee
- CH
- Contact
- Christin Dunn
- K number
- K243823
- State
- CA
- Date received
- 2024-12-12
- Review advisory committee
- CH
- Postal code
- 92130
- Decision description
- Substantially Equivalent
- Clearance type
- Traditional
- Harmonized identifiers (openFDA)
- Device name
- Interoperable Automated Glycemic Controller
- Medical specialty description
- Clinical Chemistry
- Regulation number
- 862.1356
- Device class
- 2
- Registration number
- 3013756811, 3016798778, 3016540876, 3019004087, 3008824097, 3007981285, 3026266833, 3047799708, 3014585508, 2032227, 1220477, 1220973, 3015192982, 2246552
- FEI number
- 3013756811, 3003166194, 3016798778, 3016540876, 3019004087, 3008824097, 3007981285, 3026266833, 3047799708, 3014585508, 1220477, 1220973, 3015192982, 2246552
